ORGANIC
LETTERS
2
001
Vol. 3, No. 26
237-4238
Chromium Vinylidene Carbenoids:
Stereospecific Synthesis of
4
(Z)-2-Chloroalk-2-en-1-ols
†
‡
⊥
,‡,§
D. K. Barma, Rachid Baati, Alain Valleix, Charles Mioskowski,* and
J. R. Falck*
,†
Department of Biochemistry, UniVersity of Texas Southwestern Medical Center,
Dallas, Texas 75390-9038, UniVersit e´ Louis Pasteur, Facult e´ de Pharmacie,
Laboratoire de Synth e` se Bio-Organique associe au CNRS, 67401 Illkirch, France,
and CEA de Saclay, SerVices des Molecules Marquees, Bat. 547,
91191 Gif-sur-YVette, France
Received October 18, 2001
ABSTRACT
(Z)-2-Chloroalk-2-en-1-ols are obtained in excellent yields from a wide variety of aldehydes by addition of (E)-chromium vinylidene carbenoids,
stereospecifically generated from trichloroalkanes using CrCl in THF at room temperature.
2
5
Our laboratories recently described an efficient synthesis of
terminal 2-chloropropenyl alcohols via in situ R-chloro-
vinylation of aldehydes using 1,1,1-trichloroethane and
as 3 are versatile synthetic intermediates as well as critical
structural units in a variety of biologically active natural
products of current interest. However, their accessibility
is often hampered by multistep routes and/or poor stereo-
6
1
,2
CrCl
2
.
Subsequent mechanistic investigations identified a
7
selectivity.
chromium vinylidene carbenoid as the penultimate interme-
3
The results from a panel of representative substrates are
summarized in Table 1. For simple, unactivated trichlo-
diate. Herein, we report that homologous trichloroalkanes
8
,9
1
are stereoselectively transformed to (E)-chromium vinyl-
idenes 2 which efficiently add to aldehydes affording (Z)-
(
3) Baati, R.; Barma, D. K.; Falck, J. R.; Mioskowski, C. J. Am. Chem.
Soc. 2001, 123, 9196-9197.
4) 2,2,2-Trichloroethanol derivatives also yield (Z)-2-chloroalk-2-en-
-ols accompanied by variable amounts of 1,1-dichloroalkene, (E/Z)-1-
4
2-chloroalk-2-en-1-ols 3 (eq 1). Halogenated alkenols such
(
1
chloroalkene, and 1-alkoxy-1-chloroalkene: Takai, K.; Kokumai, R.;
Nobunaka, T. Chem. Commun. 2001, 1128-1129.
(
5) (a) Taylor, R. E.; Ciavarri, J. P. Org. Lett. 2000, 1, 467-469. (b)
Dai, W.-M.; Wu, A. Tetrahedron Lett. 2001, 42, 81-83.
(
6) For example: Ueda, K.; Hu, Y. Tetrahedron Lett. 1999, 40, 6305-
6
308.
(
7) (a) Kasatkin, A.; Whitby, R. J. J. Am. Chem. Soc. 1999, 121, 7039-
7
049. (b) Kadota, J.; Komori, S.; Fukumoto, Y.; Murai, S. J. Org. Chem.
†
University of Texas.
Universit e´ Louis Pasteur.
Services des Molecules Marquees.
E-mail: mioskow@aspirine.u-strasbg.fr.
1999, 64, 7523-7527. (c) Braun, M.; Mahler, H. Liebigs Ann. 1995, 29-
40. (c) Harre, M.; Nickisch, K. Tetrahedron Lett. 1993, 34, 3123-3126.
(8) General procedure: 1,1,1-Trichloroalkane (0.4 mmol) and aldehyde
(0.4 mmol) in THF (1 mL) were added to a stirring, grayish suspension of
anhydrous CrCl2 (1.6 mmol) in THF (10 mL) under argon at ambient
temperature. After 10-12 h, the resultant reddish reaction mixture was
quenched with water and extracted thrice with ether, and the combined
ethereal extracts were evaporated in vacuo. Chromatographic purification
on SiO2 gave the (·)-chloroalkenol adducts in the indicated yields (Table
1).
‡
⊥
§
(
1) Falck, J. R.; Barma, D. K.; Mioskowski, C.; Schlama, T. Tetrahedron
Lett. 1999, 40, 2091-2094.
2) For additional examples of recent CrCl2-based methodology, see: (a)
(
Falck, J. R.; Barma, D. K.; Baati, R.; Mioskowski, C. Angew. Chem., Int.
Ed. 2001, 40, 1281-1283. (b) Baati, R.; Valleix, A.; Mioskowski, C.;
Barma, D. K.; Falck, J. R. Org. Lett. 2000, 2, 485-487.
1
0.1021/ol016935h CCC: $20.00 © 2001 American Chemical Society
Published on Web 12/06/2001